Caplin Point jumps 6% on USFDA nod for local anesthesia
Caplin Point jumps 6% on USFDA nod for local anesthesia. This is a generic therapeutic equivalent version of NAROPINInjection, of Fresenius Kabi USA LLC. Shares of Caplin Point Laboratories jumped over 6 percent after the company said it has been granted final approval from the United States Food and Drug Administration (USFDA) for its RopivacaineHydrochloride…